OpenEvidence Rolls Out Medical AI Copilot Feature to Improve AI-Generated Evidence Quality

As medical AI becomes more widely adopted, healthcare technology companies are increasingly focusing on demonstrating the reliability of AI-generated responses rather than simply delivering answers. OpenEvidence, an AI-powered medical search platform, has introduced a new copilot capability called EvidenceGrade, which evaluates and visually presents the strength of the published research used to generate responses to clinical questions. The company said the feature is designed to give physicians additional context, helping them apply medical evidence more confidently when making high-stakes clinical decisions.

According to OpenEvidence, one of the biggest shortcomings of AI systems is their tendency to summarize information from multiple sources without adequately distinguishing between stronger and weaker forms of evidence. In healthcare, that limitation can be particularly significant because findings from a randomized, double-blind, placebo-controlled clinical trial carry far more weight than results from a small empirical study conducted in a different population.

OpenEvidence Founder and Chief Executive Officer Daniel Nadler explained that EvidenceGrade addresses this challenge by assessing, quantifying, grading, and displaying the strength of the evidence underlying each response, allowing physicians to better judge how safely that information can be applied in real-world clinical practice.

Rather than only listing references, the feature evaluates the quality of the evidence supporting those sources and presents that assessment to clinicians in real time.

The launch reflects a broader industry trend in which healthcare AI companies are increasingly differentiating themselves through transparency and trust, rather than speed or accuracy alone. As generative AI systems continue to improve, demonstrating why an answer can be trusted is becoming just as important as providing it quickly.

Nadler said EvidenceGrade was created by OpenEvidence’s medical AI team, led by physician-scientists Sam Finlayson and Travis Zack, alongside lead machine learning scientists Eric Lehman and Evan Hernandez.

The feature is built on the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation), which is widely recognized as the standard for assessing the quality of medical evidence. The methodology is used by big names such as the World Health Organization, Cochrane, and numerous major clinical guideline developers.

Nadler said the development team worked with specialists in evidence synthesis and adapted established evaluation methods used by organizations such as Cochrane to meet the demands of real-time clinical decision support. He explained that the goal was to preserve rigorous evidence assessment while making it suitable for the rapid responses required by OpenEvidence.

Describing how the system works, Nadler said clinical questions are first evaluated to determine whether they are appropriate for evidence grading. Relevant research papers are then assessed for factors including certainty, quality, and relevance. He added that the AI model weighs the strength of study designs, consistency of findings, precision across multiple sources, and how directly the available evidence addresses the clinical question, closely reflecting the way an experienced evidence-review expert would evaluate a body of research.

Then, grades are given from ‘A’ to ‘D’, with the former signifying that the evidence is supported by the near-perfect study designs, while the latter is assigned when no grade can be given. 

OpenEvidence has introduced its new Medical AI Copilot feature, marking another milestone in the evolution of artificial intelligence for healthcare professionals. The latest OpenEvidence enhancement is designed to improve the quality, transparency, and reliability of AI-generated medical evidence, helping clinicians access trustworthy information more efficiently. As AI adoption continues to expand across healthcare, OpenEvidence aims to strengthen confidence in AI-assisted clinical decision-making.

What Is the OpenEvidence Medical AI Copilot?

The OpenEvidence Medical AI Copilot is an advanced AI-powered assistant built to support physicians and other healthcare professionals with evidence-based clinical information. Rather than simply generating responses, OpenEvidence focuses on delivering medically relevant answers backed by trusted research, clinical guidelines, and peer-reviewed literature. This approach helps users quickly verify information while reducing the risk of unsupported AI-generated content.